Federal Register / Vol. 86, No. 37 / Friday, February 26, 2021 / Notices 11781 

Responses: 30,249; Total Annual Hours: 

6,902. (For policy questions regarding 

this collection contact Alesia Hovatter at 

410–786–6861.) 

Dated: February 23, 2021. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2021–04056 Filed 2–25–21; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Charter Renewal for the Advisory 

Council on Blood Stem Cell 

Transplantation 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, HHS 

is hereby giving notice that the Advisory 

Council on Blood Stem Cell 

Transplantation (ACBSCT or Council) 

has been rechartered. The effective date 

of the recharter is February 19, 2021. 

FOR FURTHER INFORMATION CONTACT: 

Robert Walsh, Executive Secretary, 

Advisory Council on Blood Stem Cell 

Transplantation, HRSA, 5600 Fishers 

Lane, Room 08W60, Rockville, 

Maryland 20857. Phone: (301) 443– 

6839; email: ACBSCTHRSA@hrsa.gov. 

SUPPLEMENTARY INFORMATION: ACBSCT 

provides advice and recommendations 

to the Secretary of HHS (Secretary) on 

policy, program development, and other 

matters of significance concerning the 

activities under the authority of 42 

U.S.C. 274k; Section 379 of the Public 

Health Service Act. The Council is 

governed by the provisions of Public 

Law 92–463, as amended (5 U.S.C. 

appendix 2), which sets forth standards 

for the formation and use of advisory 

committees. 

ACBSCT advises and makes 

recommendations to the Secretary on 

matters related to the activities of the 

C.W. Bill Young Cell Transplantation 

Program and the National Cord Blood 

Inventory Program. One of its principal 

functions is to provide a consolidated, 

comprehensive source of expert, 

unbiased analysis and recommendations 

to the Secretary on the latest advances 

in the science of blood stem cell 

transplantation. 

The recharter for ACBSCT was 

approved on February 18, 2021, and 

filed on February 19, 2021. Recharter of 

ACBSCT gives authorization for the 

Council to operate until February 19, 

2023. 

A copy of the ACBSCT charter is 

available on the ACBSCT website at 

https://bloodcell.transplant.hrsa.gov/ 

about/advisory_council/index.html. A 

copy of the charter can also be obtained 

by accessing the FACA database that is 

maintained by the Committee 

Management Secretariat under the 

General Services Administration. The 

website address for the FACA database 

is http://www.facadatabase.gov/. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2021–03990 Filed 2–25–21; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Arthritis and 

Musculoskeletal and Skin Diseases; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel: Ancillary 

Studies Review Meeting. 

Date: March 24, 2021. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Arthritis and 

Musculoskeletal and Skin Diseases, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Virtual 

Meeting). 

Contact Person: Nakia C. Brown, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute of Arthritis, 

Musculoskeletal and Skin Diseases, 6701 

Democracy Boulevard, Room 816, Bethesda, 

MD 20892, (301) 827–4905, brownnac@

mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS) 

Dated: February 22, 2021. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–03939 Filed 2–25–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center For Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel 

Member Conflict: Pathobiology of 

Alzheimer’s Disease. 

Date: March 19, 2021. 

Time: 12:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Aleksey Gregory 

Kazantsev, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 5201, MSC 7846, Bethesda, MD 20817, 

(301) 435–1042, aleksey.kazantsev@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Societal and 

Ethical Issues in Research. 

Date: March 24, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Benjamin Greenberg 

Shapero, Ph.D., Scientific Review Officer, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 3182, Bethesda, MD 20892, (301) 402– 

4786, shaperobg@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA–TR– 

20–001: Ethical issues in Translational 

Science Research. 

Date: March 24, 2021. 

Time: 12:00 p.m. to 6:00 p.m. 


khammond on DSKJM1Z7X2PROD with NOTICES